Fertility and Sterility
Volume 93, Issue 1 , Pages 62-67 , 1 January 2010

Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting

  • Katy Vincent, M.B.B.S.

      Affiliations

    • Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Headley Way, Oxford, United Kingdom
    • Corresponding Author InformationReprint requests: Dr. Katy Vincent, Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU (FAX: 00-44-1865-222727).
    • ,
  • Stephen Kennedy, M.D.

      Affiliations

    • Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Headley Way, Oxford, United Kingdom
    • ,
  • Pamela Stratton, M.D.

      Affiliations

    • Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland

Received 4 March 2008 ,Revised 17 September 2008 ,Accepted 17 September 2008.

References 

  1. Streiner DL, Norman G. Health Measurement Scales—a practical guide to their development and use. 3d ed. Oxford: Oxford University Press; 2003;
  2. Biberoglu KO, Behrman SJ. Dosage aspects of danazol therapy in endometriosis: short term and long term effectiveness. Am J Obstet Gynecol. 1981;139:645
  3. Lemay A, Maheux R, Hout C, Blanchet J, Faure N. Efficacy of intranasal or subcutaneous luteinizing hormone–releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis. Am J Obstet Gynecol. 1988;158:233–236
  4. Hornstein MD, Yuzpe AA, Burry KA, Heinrichs LR, Buttram-VL J, Orwoll ES. Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain. Fertil Steril. 1995;63:955–962
  5. Shaw RW. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Fertil Steril. 1992;58:265–272
  6. Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani PG. Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod. 2007;22:266–271
  7. Szendei G, Hernadi Z, Devenyi N, Csapo Z. Is there any correlation between stages of endometriosis and severity of chronic pelvic pain? Possibilities of treatment. Gynecol Endocrinol. 2005;21:93–100
  8. Mahmood T, Templeton A, Thomson L, Fraser C. Menstrual symptoms in women with pelvic endometriosis. Br J Obstet Gynecol. 1991;98:558–563
  9. Anaf V, Simon P, El Nakadi I, Fayt I, Buxant F, Simonart T, et al. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod. 2000;15:1744–1750
  10. Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science. 2005;308:1587–1589
  11. Bodner CH, Garratt AM, Ratcliffe J, Macdonald LM, Penney G. Measuring health-related quality of life outcomes in women with endometriosis-results of the Gynaecology Audit Project in Scotland. Health Bull (Edinb). 1997;55:109–117
  12. Abbott JA, Hawe J, Clayton RD, Garry R. The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2–5 year follow-up. Hum Reprod. 2003;18:1922–1927
  13. Marques TEA, Bahamondes L, Aldrighi JM, Petta CA. Quality of life in Brazilian women with endometriosis assessed through a medical outcome questionnaire. J Reprod Med. 2004;49:115–120
  14. Jones G, Jenkinson C, Kennedy S. The impact of endometriosis upon quality of life: a qualitative analysis. J Psycho Som Obs Gyn. 2004;25:123–133
  15. Jones G, Jenkinson C, Kennedy S. Development of the Short Form Endometriosis Health Profile Questionnaire: the EHP-5. Qual Life Res. 2004;13:695–704
  16. Jones G, Kennedy S, Barnard A, Wong J, Jenkinson C. Development of an Endometriosis Quality-of-Life Instrument: The Endometriosis Health Profile-30. Obstet Gynecol. 2001;98:258–264
  17. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Sing. 1994;23:129–138
  18. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106:337–345
  19. Stegmann BJ, Sinaii N, Liu S, Segars J, Merino M, Nieman LK, et al. Using location, color, size, and depth to characterize and identify endometriosis lesions in a cohort of 133 women. Fertil Steril. 2008;89:1632–1636
  20. American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2006;86:S18–S27
  21. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20:2698–2704
  22. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9–19
  23. Guy W. ECDEU assessment manual for psychopharmacology. Washington, D.C: U.S. Government Printing Office; 1976;
  24. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67:817–821
  25. Moher D, Schulz KF. Altman DG, for the CG. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. Ann Intern Med. 2001;134:657–662

 K.V. has received funding from Pfizer. S.K. has received grant support from Pfizer and is on the advisory boards of TAP Pharmaceuticals, Takeda, and Bayer Schering-Plough. P.S. has nothing to disclose.

 This study was supported by the Intramural Program of the National Institute of Child Health and Human Development and unrestricted educational grants from Ferring, Neurocrine, Pfizer, Schering, Takeda, and TAP Pharmaceuticals.

PII: S0015-0282(08)04049-1

doi: 10.1016/j.fertnstert.2008.09.056

Fertility and Sterility
Volume 93, Issue 1 , Pages 62-67 , 1 January 2010

Article Tools